NZ554385A - 2-Acylaminothiazole derivatives having affinity for the adenosine 2A - Google Patents
2-Acylaminothiazole derivatives having affinity for the adenosine 2AInfo
- Publication number
- NZ554385A NZ554385A NZ554385A NZ55438505A NZ554385A NZ 554385 A NZ554385 A NZ 554385A NZ 554385 A NZ554385 A NZ 554385A NZ 55438505 A NZ55438505 A NZ 55438505A NZ 554385 A NZ554385 A NZ 554385A
- Authority
- NZ
- New Zealand
- Prior art keywords
- phenyl
- thiazol
- oxadiazol
- methyl
- tetrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200401441 | 2004-09-22 | ||
| PCT/DK2005/000591 WO2006032273A1 (en) | 2004-09-22 | 2005-09-20 | 2-acylaminothiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ554385A true NZ554385A (en) | 2010-01-29 |
Family
ID=37398231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ554385A NZ554385A (en) | 2004-09-22 | 2005-09-20 | 2-Acylaminothiazole derivatives having affinity for the adenosine 2A |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JP4942045B2 (xx) |
| KR (1) | KR20070054669A (xx) |
| CN (1) | CN101061115A (xx) |
| AR (1) | AR050653A1 (xx) |
| BR (1) | BRPI0515519A (xx) |
| ES (1) | ES2457091T3 (xx) |
| IL (1) | IL182001A0 (xx) |
| NZ (1) | NZ554385A (xx) |
| SG (1) | SG155924A1 (xx) |
| ZA (1) | ZA200702325B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI473614B (zh) * | 2008-05-29 | 2015-02-21 | Kyowa Hakko Kirin Co Ltd | Anti-analgesic inhibitors |
| NZ590793A (en) * | 2008-07-23 | 2012-07-27 | Kyowa Hakko Kirin Co Ltd | Therapeutic agent for migraine |
| CN109293652B (zh) * | 2017-07-24 | 2021-10-22 | 四川科伦博泰生物医药股份有限公司 | 一种取代的噻唑衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2302417A1 (en) * | 1997-10-27 | 1999-05-06 | Takeda Chemical Industries, Ltd. | Adenosine a3 receptor antagonists |
| AU4506399A (en) * | 1998-06-05 | 1999-12-30 | Novartis Ag | Aryl pyridinyl thiazoles |
| JP2002302488A (ja) * | 2000-03-30 | 2002-10-18 | Takeda Chem Ind Ltd | 置換１，３−チアゾール化合物、その製造法および用途 |
| GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
-
2005
- 2005-09-20 NZ NZ554385A patent/NZ554385A/en not_active IP Right Cessation
- 2005-09-20 ES ES05784170.2T patent/ES2457091T3/es active Active
- 2005-09-20 KR KR1020077006461A patent/KR20070054669A/ko not_active Application Discontinuation
- 2005-09-20 CN CNA2005800398643A patent/CN101061115A/zh active Pending
- 2005-09-20 JP JP2007531600A patent/JP4942045B2/ja not_active Expired - Fee Related
- 2005-09-20 ZA ZA200702325A patent/ZA200702325B/xx unknown
- 2005-09-20 BR BRPI0515519-3A patent/BRPI0515519A/pt not_active IP Right Cessation
- 2005-09-20 SG SG200906145-8A patent/SG155924A1/en unknown
- 2005-09-21 AR ARP050103961A patent/AR050653A1/es not_active Application Discontinuation
-
2007
- 2007-03-18 IL IL182001A patent/IL182001A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0515519A (pt) | 2008-07-29 |
| JP2008513385A (ja) | 2008-05-01 |
| ES2457091T3 (es) | 2014-04-24 |
| SG155924A1 (en) | 2009-10-29 |
| IL182001A0 (en) | 2007-07-04 |
| CN101061115A (zh) | 2007-10-24 |
| JP4942045B2 (ja) | 2012-05-30 |
| ZA200702325B (en) | 2008-10-29 |
| AR050653A1 (es) | 2006-11-08 |
| KR20070054669A (ko) | 2007-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060154974A1 (en) | N-thiazol-2-yl-benzamide derivatives | |
| AU2005205201B2 (en) | Thiazole derivatives and use thereof | |
| EP1794157B1 (en) | 2-acylaminothiazole derivatives | |
| US20040053973A1 (en) | Substituted 1,3-thiazole compounds, their production and use | |
| CA2723396A1 (en) | Benzene sulfonamide thiazole and oxazole compounds | |
| BRPI0807626B1 (pt) | Processo para a síntese de compostos de 2-aminotiazol como inibidores de quinase | |
| CN101208089A (zh) | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 | |
| DE69902754T2 (de) | Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren | |
| AU2009209885A1 (en) | Thiazole derivative and use thereof as VAP-1 inhibitor | |
| AU2007217575A1 (en) | 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
| CA2965515A1 (en) | Thiazoles as modulators of ror.gamma.t | |
| NZ554385A (en) | 2-Acylaminothiazole derivatives having affinity for the adenosine 2A | |
| EP2855470A1 (en) | Novel bicyclic thiazole compounds | |
| CA3109623C (en) | Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease | |
| ZA200602907B (en) | N-Thiazol-2-yl-benzamide derivatives | |
| CA2606011A1 (en) | Pro-drugs of n-thiazol-2yl-benzamide derivatives | |
| WO2017102014A1 (en) | Propenamide thiophene derivatives as flavivirus inhibitors and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| LAPS | Patent lapsed |